# Continuous Glucose Monitor Use in Pregnancy

Study · id `cardio:ct-nct05317585` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05317585](<https://clinicaltrials.gov/study/NCT05317585>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05317585

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

## Technical summary

Registry record NCT05317585. Randomized; no masking; primary purpose prevention. Start 2024-05-23 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT05317585, source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)
- Started: 2024-05-23 (actual) (ClinicalTrials.gov record NCT05317585, source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05317585, source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)
- Completion: 2027-07-01 (anticipated) (ClinicalTrials.gov record NCT05317585, source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05317585, source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05317585-2026-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Glucose Monitor Use in Pregnancy
- Condition: Type 2 Diabetes Treated With Insulin
- Condition: Pregnancy, High Risk
- Intervention (Device): Continuous Glucose Monitor
- Intervention (Device): Routine Capillary Blood Glucose Monitoring (Fingerstick Glucose)
- Lead sponsor: University of Massachusetts, Worcester
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Massachusetts, Worcester (`cardio:org-university-of-massachusetts-worcester`)

## Provenance

Content hash: 78c5b2a4de97db468da67641bea0fb3e950a0a2b070e32e9a5201550eb383b43
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
